SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

05 Aug 2023 Evaluate
A decent increase of about 34.51% in the sales to Rs. 3691.03 millions was observed for the quarter ended June 2023. The sales figure stood at Rs. 2743.97 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 130.53% to Rs. 158.49  millions  from Rs. 68.75 millions in previous same quarter.The company reported a good operating profit of 268.87 millions compared to 143.18 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 3691.03 2743.97 34.51 3691.03 2743.97 34.51 13388.83 14492.67 -7.62
Other Income 20.84 7.09 193.94 20.84 7.09 193.94 57.59 102.35 -43.73
PBIDT 268.87 143.18 87.78 268.87 143.18 87.78 830.29 1393.72 -40.43
Interest 2.83 3.95 -28.35 2.83 3.95 -28.35 19.81 -73.66 -126.89
PBDT 266.04 139.23 91.08 266.04 139.23 91.08 810.48 1467.38 -44.77
Depreciation 48.93 43.71 11.94 48.93 43.71 11.94 180.06 211.95 -15.05
PBT 217.11 95.52 127.29 217.11 95.52 127.29 630.42 1255.43 -49.78
TAX 58.62 26.77 118.98 58.62 26.77 118.98 167.99 244.82 -31.38
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 2.03 24.83 -91.82
PAT 158.49 68.75 130.53 158.49 68.75 130.53 462.43 1010.61 -54.24
Equity 1022.27 998.27 2.40 1022.27 998.27 2.40 1022.27 955.59 6.98
PBIDTM(%) 7.28 5.22 39.60 7.28 5.22 39.60 6.20 9.62 -35.51

Morepen Laboratories Share Price

41.92 0.79 (1.92%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×